Pfizer Inc. (NYSE: PFE) is one of the best undervalued stocks to buy under $50. Pfizer Inc. (NYSE:PFE) received a rating ...

Companies don’t generally cut prices out of generosity.

In today’s Pharmaceutical Executive Daily, we report on new data showing Wegovy’s potential to reduce liver injury in patients with MASH, Eli Lilly’s latest strategic collaborations in gene therapy, ...

The company's shares (LLY) climbed 2.3% Tuesday to end at $988.62 a share, after closing at a record high of $966.64 on Monday. The rally has pushed Lilly's market capitalization up to $934.6 billion, ...

Multiple people across the globe who stepped forward are speaking about what they say is the debilitating aftermath they now ...

The U.S. Department of Health and Human Services and the U.S. Food and Drug Administration announced that Richard Pazdur, M.D., has been appointed ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

Sarah Hall is leaving her role as president of FCB Health New York. The 2025 MM+M Agency 100 honoree confirmed the personnel move in a statement to MM+M on Tuesday afternoon. “Sarah Hall has decided ...

What Happened: According to Reuters, Pfizer Inc (NYSE: PFE) won the bidding war against Novo Nordisk and will purchase ...

The first thing that comes to mind when we speak about the S&P 500 is the biggest tech companies, high valuations, and ...

There’s room for more than one winner in this race for GLP-1 weight loss supremacy, but some of these winners are going to be ...